chrisvoncsefalvay/vaers-outcomes huggingface dataset:
under 18 years old, received the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old, received the vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old, received the vaccine). On 18-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old, received the vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment information was provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
pt recvd vax; on 26nov95 febrile episode >103 w/ sz & apnea; dx w/ otitis med in er; tx w/ atb's; EEG to be done 14dec95;
Day of vaccines - right upper arm red, firm, warm to touch, resolved 5/14/10 - no fever.
Extreme headache concentrated on right side of the head from base on head curving up to the top of the right ear. Swollen lymph node above right collar bone. Head pain decreased over time to a dull pain over two week period. Dull pain still present today (today's date is 06.22.2021). Pain increased when lighting heavier objects or when laying down.  Pain in right arm has been present since the vaccine and is still present when arm is in certain positions.  Diagnosed with Lymphadenopathy.
Swollen upper right arm, redness down to elbow, soreness. Began one day after administration. Also experienced headache and malaise.
Brought to her attention the sucrose in the vaccine information. She stated she would be fine.  Gave vaccination and instructed employee to stay in hospital for at least 15- 30 minutes.  Employee walked back into vaccine clinic at 1109 and states she isn't feeling well, slight rash noted at injection site and slight rash on chest.  Employee is anxious do to previous issue mentioned above.  Took employee to EHS.  BP 215/107 P 122, shaking feels like right side of her throat is slightly swollen no SOB, Pulse ox 98%  P 133.  BRRT called at 1112. Employee states she took Benadryl 25 mg before coming to get vaccine. States she was walking in hall and started not feeling well so took Benadryl 25mg.  1116 BP 198/106 P135.  BRRT staff here and assessing employee. T98.2 at 1119.  1121 BP 186/ 91 P 107.  Employee reports she is feeling better now bumps in her mouth or swelling in her throat, less shaking redness in chest and right arm decreased.  Employee refused to go to ED signed  refusal form.  1126 BP 189/96 P92 BRRT team still here. Employee will continue to be monitored in EHS.    BP 177/87 P87 feeling much better ready to leave EHS.
had flu like symptoms for a week; a fever of 101 degree F to 103 degree F for a week; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (had flu like symptoms for a week) and PYREXIA (a fever of 101 degree F to 103 degree F for a week) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032f21a, 012m20a and 027a21a) for COVID-19 vaccination.     Patient had no allergies. Patient has never been diagnosed or tested positive for COVID-19. The patient had no history relating to mentioned adverse event or both Acute and Chronic illnesses at the time of vaccination.  Concurrent medical conditions included Cholesterol and Blood pressure. Concomitant products included VITAMINS NOS for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (had flu like symptoms for a week) and PYREXIA (a fever of 101 degree F to 103 degree F for a week). At the time of the report, INFLUENZA LIKE ILLNESS (had flu like symptoms for a week) and PYREXIA (a fever of 101 degree F to 103 degree F for a week) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 degree fahrenheit to 103 degree fahrenheit (High) 101 degree Fahrenheit to 103 degree Fahrenheit.         It was reported that no other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Concomitant medications also included low dose of cholesterol medicine and low dose blood pressure medicine.  The patient received first booster dose on 08-Nov-2021 with lot number 032f21a.  The events did not cause patient to seek medical care.  No treatment drug was reported.   This case was linked to MOD-2022-561898, MOD-2022-561901, MOD-2021-177679 (Patient Link).
Sore throat in the afternoon, followed by body ache that night. Congestion in the nose, patient hard a hard time breathing, hard time sleeping at night. In bed all day and had to go to the doctor. Random coughing till date.
Client received first dose of COVID vaccine Pfizer Lot# FF2587 in left arm. Client came to site today (11/16/2021) requesting second dose of COVID vaccine Pfizer. Client reported to RN that after receiving first dose on 10/26/2021 feeling "dizzy and a little bit of chest pain." Client reports seeing spots, denies passing out. Client reports staff fed her a snack due to she didn't eat that day. Client reports she has symptoms for a "little bit," and they resolved before she left after her 15 min observation. RN requested PHN assess client. Client reported to PHN, she felt anxious during and after receiving the vaccine that day. Client denies history of reactions to other vaccines, reports history of anxiety attacks. Client has allergies to pollen and environment, denies anaphylaxis. PHN text Operation Vaccination Lead, at 2:20 pm for medical consult. Per Dr., client approved to get 2nd COVID vaccine Pfizer today. Client given juice before vaccination. Client received COVID vaccine Pfizer lot #FF8841 at 3:10 pm in the left arm. Client stayed for 30 minute observation period, denied s/s of adverse reaction. Client walked out with her mother with a steady gait.
Another young man in 30's in same community also reported eye problems after shot; This is a spontaneous report from a non-contactable consumer. A 4-decade-old (in his 30's) male patient received bnt162b2 (Formulation: solution for injection), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that 'another young man in 30's in same community also reported eye problems after shot' on an unknown date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Golfball sized lump at injections site, painful, red, warm to the touch.
12JUN95 swelling & redness (right away & lasted 1 1/2 days); 17JUN 11AM became limp & unresponsive, no resp; no fever present; adm to ER where resp care gave minimal assistance w/2 breaths; adm to hosp given Phenobarbital;
pain in the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in the arm of injection) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in the arm of injection). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (pain in the arm of injection) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications also included 'Woman Vitamin' for nails.   This case was linked to MOD-2021-114356 (Patient Link).
flu-like symptoms; This is a spontaneous report from a contactable physician (Pediatrician) via Pfizer Sponsored Program, who reported similar events for three patient. This is 3rd of three reports.   A male patient of an unspecified age who attended the University received the 1st dose of meningococcal group b rlp2086 (TRUMENBA) at single dose on an unspecified date for immunization at college (not by the reporting physician). The reporter thought it happened around 5 years before this report but not sure. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced flu-like symptoms. Two days after vaccination patient came to the reporting physician (who was their pediatrician at home) complaining of flu-like symptoms (e.g., tired, heavy feeling, achy, maybe fever). Health care professional was not overly concerned and told him to take OTC products to remedy and the symptoms resolved in a couple of days. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019481019 Same reporter/ drug/ event for different patients;US-PFIZER INC-2019480953 Same reporter/ drug/ event for different patients
feel pressure on her bladder; her vagina and tongue are burning; her vagina and tongue are burning; This is a spontaneous report from a contactable consumer (Patient). A 68-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9261), via an unspecified route of administration, in left arm on 27Jan2021 as single dose for COVID-19 immunization. The patient was 68-year-old at time of vaccination. Patient relevant medical history included genital herpes (her husband cheated on her in her 20s when she was diagnosed) and allergic to hair dye (had reaction to the permanent wave in the 1980s). There were no concomitant medications. On unspecified date in 2021, the patient experienced feel pressure on her, her vagina and tongue are burning, 2-3 days after vaccine. Patient reporting adverse event to the Pfizer COVID vaccine, stated she developed a bladder infection. She went to the doctor she was prescribed antibiotics. She took the product for 2 days and her symptoms were worse. Product was Cephalexin, 500mg three times a day by mouth, dispensed in a pharmacy name vial, NDC, Lot, and Expiration date unknown. manufacturer unknown. The patient underwent lab tests and procedures which included urine analysis was negative. She performed urine tests to confirm or discard a bladder infection and the results came negative. Therapeutic measures were taken as result of feel pressure on her bladder. The outcome of event was not recovered.  Follow-up attempts are completed. No further information is expected.
pt. experiencing burning sensation to bilat. upper extremities, dizziness & burning vision.  on-site medics present.  Medic administered benadryl 50mg IM to the L arm at 1057.   pt declined EMS/ER.  Symptoms resolved w/ benadryl.  BP: 133/99, HR: 199, RR: 20
12/20/2020 10 mins post vaccine I  was sitting reading and my heart started to race fast and strong I had a tingly feeling and then I got dizzy. I had crackers and water and put my feet up, I felt a little better and went home and was cleaning the house and my heart started to race again on and off all that day I called 911 and they took my BP and said I wasn't in distress enough to go to the ER and was told not to get the second dose and it went away the next day and I've felt better.
loss of hearing. pt. contacted dr her pcp. priscribed medrol dose pack. pt. saw dr. ENT specialist next day. He agrred with the course of steroid. NOw the steroid has been complted the hearing loss is coming back to her. She will be seeing Dr. soon again.
TOE TURNED BLUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On APR-2021, the subject experienced toe turned blue. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from toe turned blue on APR-2021. This report was non-serious.
Pt received flu shot and has been ill since that time. She has had a lot of pain and weakness in legs & arms. Doctor said she had Guillain-Barre syndrome. She is very weak and is all alone has no one to help her. Received information from her friend because pt is deaf.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 28Mar2022 as dose 1, single (Batch/Lot number: unknown), in left arm, on 25Apr2022 as dose 2, single (Batch/Lot number: unknown), in left arm and on 02Jun2022 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
sinus infection; This is a spontaneous report from a contactable consumer (patient) communicated via regulatory authority.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had sinus infection. It was reported that the patient wanted to know if it was okay to take second dose while she was on antibiotics for sinus infection on an unspecified date. The patient was received unspecified antibiotics treatment for the events. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse concerning a 17 year old female patient who on 07-AUG-2007 was vaccinated IM with a first dose of Gardasil.  The nurse reported that after receiving her first dose of Gardasil she developed swelling and rash with joint pain on her lower extremities.  Laboratory tests showed that she had "Strep" and MEDROL dose pack was prescribed.  No further information was available.  The patient recovered.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 10/12/2007. Information has been received from a nurse concerning a 17 year old female patient who on 23-AUG-2007 (also reported as 07-AUG-2007) was vaccinated with a first dose of GARDASIL vaccine. Follow-up information was received from a medical assistant. On 25-SEP-2007, the patient returned to the office for a follow-up visit. The patient had no further problems and was recovered. The patient did no continue the GARDASIL vaccine series of vaccination. Additional information is not expected.
Heart beating abnormally strong and fast for 10 days after shot.   Weird compression feeling would occasionally shift from one side of heart to the other. I suspect the Pzizer vaccine inflamed my heart.  Possible Myocarditis or Pericarditis.
Her arm is paining; Bad rash; Redness; Itchy at the site of injection on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm is paining), VACCINATION SITE RASH (Bad rash), VACCINATION SITE ERYTHEMA (Redness) and INJECTION SITE PRURITUS (Itchy at the site of injection on her left arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Diabetes since an unknown date.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Her arm is paining), VACCINATION SITE RASH (Bad rash), VACCINATION SITE ERYTHEMA (Redness) and INJECTION SITE PRURITUS (Itchy at the site of injection on her left arm). At the time of the report, PAIN IN EXTREMITY (Her arm is paining), VACCINATION SITE RASH (Bad rash), VACCINATION SITE ERYTHEMA (Redness) and INJECTION SITE PRURITUS (Itchy at the site of injection on her left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Light head spells , almost passiing out, increased heart rate st times, shaking,  headaches
Nurse reported VAQTA was administered after improper storage; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies and drug allergy or reactions were not reported.      On 03-AUG-2023, the patient was vaccinated with one dose of improper storage vaccine hepatitis a vaccine, inactivated (VAQTA) vial (lot # X003791, expiration date: 01-JUN-2024) (strength and route were not reported) for prophylaxis (product storage error). It was unknown of hepatitis a vaccine, inactivated (VAQTA) was prefilled syringe or vial, however it was known that it was a pediatric dose administered. The operator of the device was a healthcare professional.   The vaccine underwent temperature excursion of 51 degrees Fahrenheit for 1 hour. There were no previous temperature excursions. No adverse effects were reported.; Sender's Comments:  US-009507513-2308USA006792: US-009507513-2308USA006780: US-009507513-2308USA006923: US-009507513-2308USA006991: US-009507513-2308USA006972:
Began with fussiness and fever of 101.5; fever evolved to 102 by Thursday.  Has been fussy and continues to have fever (101.9)--today is Sunday, more than 96 hours after. Fever is resistant to ibuprofen. Drops a degree only to rise back to 102 within 2 hours. Placed call to ped on 6/11.  Coughing and runny nose began on Friday.  Coughing is preventing sleep and sounds like a seal barking.  Took to hospital ER at 11 PM on 6/13.  They noted fever and diagnosed bronchitis.  Took a 7 hour nap today and then went back to bed--excessive tiredness.  He showed no sign of illness before the shot.  There are 2 adults and 3 other children in the house, all healthy.
"vaccine" for Covid-19 if it doesn't work?; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), outcome "unknown", described as ""vaccine" for Covid-19 if it doesn't work?". Clinical course: Why would I take your stupid (Abusive word) "vaccine" for Covid-19 if it doesn't work? Quit marketing your (Abusive word).  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Patient received 2 flu shots. She had already received a flu shot at another location.  No issues at time patient left.
Patient describes having a small, red welt 2 inches below injection site which was also warm to touch. Welt grew to 4 x 6 inches in days and remained warm to touch.
Fever 101 Chills Severe body aches Headache Diarrhea
Initial report received from non-health care professional (consumer) on 27 January 2013. This case is linked to case number 2014SA011913 (same patient). A 60-year-old female patient has received intradermally 1st dose of FLUZONE ID (lot number was unknown) in the left deltoid on 27 January 2013. The patient had no illness at time of vaccination. Te patient had allergy to many chemicals and drugs. On 27 January 2013, same day of administration the patient developed left arm sore, quarter size reddened area that was red and hot that was painful, low grade fever, malaise for a few week, pea size reddened and hard area which was raised. Laboratory investigations and corrective treatment were not reported. At the time of this report, the patient was not recovered. The patient required ER/doctor visit. List of documents held by sender: none  Follow up information received from non-health care professional (consumer) on 19 March 2014. The details include lot number: 4T47198A, and expiration date 04-02-2014. The patient has chemical insensitivity not specific; also have metal allergy, Inderal allergy, peanuts allergy, latex intolerance, latex sensitivity, amoxacillin intolerance. The patient has severe reaction to rabies vaccine many years ago. It was also reported that redness at site for two weeks and able to peel lump under skin.
Facial swelling and redness, nasal congestion, and nausea. Seen in ER Friday, 10/15, treated with steroiods, Benadryl, IVF and released. Seen by Primary care Physician Mon. 10/18.
Swelling of left arm pneumonia shot, T 101.0, red, swelling from shoulder to elbow within a few days.
pt screamed inconsolably most of evening & into noc; ran a fever of 104+ for day & 103 for another day; started approx 6PM p/shots;
Patient complained of pain in the arm two weeks after receiving vaccine. Consulted an orthopedic regarding the pain and they recommended an MRI. The MRI results came back negative for Hematoma at the site of administration. Patients Daughter called the pharmacy 12/31/20 stating the patient is still in pain and she now has arthritis in the arm due to not being able to use the arm from the pain since being vaccinated.